Register entryShortage reported
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Data as of · How to read this entry
- Registered sites
- 4
- Active NDC listings
- 28
- Live patents
- 0
- Shortage listings
- 13
- Countries
- 1
- Base
- China
Authorisation
Registered operations
Analytical testing4Active ingredient (API) manufacture1Labelling3Finished drug manufacture3Packaging3particle size reduction1sterilize3
Sites
Registered establishments
4| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Dongjin Road Site)Registrant: Jiangsu Hengrui Pharmaceuticals Co., Ltd. | Dongjin Road, Port Industry Area, Economic and Technological Development Zone, Lianyungang, Jiangsu 222069, China (CHN) | Analytical testing, Labelling, Finished drug manufacture, Packaging, sterilize | 3003404148421324417 |
| Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Huaguoshan Avenue Lab)Registrant: Jiangsu Hengrui Pharmaceuticals Co., Ltd. | 567-3 Huaguoshan Avenue, 3rd Floor, Economic and Technological Development Zone, Lianyungang, Jiangsu 222069, China (CHN) | Analytical testing | 3011603969699370190 |
| Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Huanghe Road Site)Registrant: Jiangsu Hengrui Pharmaceuticals Co., Ltd. | 38 Huanghe Road, Economic and Technological Development Zone,, Lianyungang, Jiangsu 222047, China (CHN) | Analytical testing, Labelling, Finished drug manufacture, Packaging, sterilize | 3007373503421251868 |
| Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Jinqiao Road Site)Registrant: Jiangsu Hengrui Pharmaceuticals Co., Ltd. | 22 Jinqiao Road, Dapu Industrial Park, Economic and Technological Development Zone, Lianyungang, Jiangsu 222069, China (CHN) | Analytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging, particle size reduction, sterilize | 3006689263699507972 |
Alert
Drug shortage listings
13| Drug | Presentation | Status | Availability | Posted / updated |
|---|---|---|---|---|
| Dexmedetomidine Hydrochloride InjectionAnesthesia | Dexmedetomidine Hydrochloride, Injection, 80 mcg/20 mL (NDC 0781-3493-95) | Current | Available | 10 Apr 202015 Sept 2026 |
| Dexmedetomidine Hydrochloride InjectionAnesthesia | Dexmedetomidine Hydrochloride, Injection, 200 mcg/50 mL (NDC 0781-3494-95) | Current | Available | 10 Apr 202015 Sept 2026 |
| Dexmedetomidine Hydrochloride InjectionAnesthesia | Dexmedetomidine Hydrochloride, Injection, 400 mcg/100 mL (NDC 0781-3495-95) | Current | Available | 10 Apr 202015 Sept 2026 |
| Gadobutrol InjectionMedical Imaging | Gadobutrol, Injection, 604.72 mg/mL (NDC 65219-281-15) | To Be Discontinued | - | 30 Jun 202630 Jun 2026 |
| Gadobutrol InjectionMedical Imaging | Gadobutrol, Injection, 604.72 mg/mL (NDC 65219-281-07) | To Be Discontinued | - | 30 Jun 202630 Jun 2026 |
| Gadobutrol InjectionMedical Imaging | Gadobutrol, Injection, 604.72 mg/mL (NDC 65219-281-10) | To Be Discontinued | - | 30 Jun 202630 Jun 2026 |
| Gadobutrol InjectionMedical Imaging | Gadobutrol, Injection, 604.72 mg/mL (NDC 65219-281-02) | To Be Discontinued | - | 30 Jun 202630 Jun 2026 |
| Gadoterate Meglumine InjectionMedical Imaging | Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-084-15) | To Be Discontinued | - | 30 Jun 202630 Jun 2026 |
| Gadoterate Meglumine InjectionMedical Imaging | Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-082-10) | To Be Discontinued | - | 30 Jun 202630 Jun 2026 |
| Gadoterate Meglumine InjectionMedical Imaging | Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-080-05) | To Be Discontinued | - | 30 Jun 202630 Jun 2026 |
| Gadoterate Meglumine InjectionMedical Imaging | Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-086-20) | To Be Discontinued | - | 30 Jun 202630 Jun 2026 |
| Oxaliplatin InjectionOncology | Oxaliplatin, Injection, 5 mg/1 mL (NDC 25021-233-20) | To Be Discontinued | - | 29 Jun 202629 Jun 2026 |
| Oxaliplatin InjectionOncology | Oxaliplatin, Injection, 5 mg/1 mL (NDC 25021-233-10) | To Be Discontinued | - | 29 Jun 202629 Jun 2026 |
Catalogue
Drug listings by form and route
2828 active NDC listings: 23 bulk ingredient, 5 human prescription drug. By marketing category: BULK INGREDIENT 23, ANDA 5.
| Dosage form | NDCs |
|---|---|
| powder | 21 |
| injection, solution, concentrate | 3 |
| injection, suspension, liposomal | 2 |
| liquid | 2 |
| Route | NDCs |
|---|---|
| intravenous | 3 |
| infiltration | 2 |
| Labeller name on the listing | NDCs |
|---|---|
| jiangsu hengrui pharmaceuticals co., ltd. | 28 |
Catalogue
Marketed products
28| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | Bupivacaine | powder | 57884-0038BULK INGREDIENT |
| Bupivacaine | Bupivacaine | injection, suspension, liposomal, infiltration | 57884-3251ANDA |
| Bupivacaine | Bupivacaine | injection, suspension, liposomal, infiltration | 57884-3252ANDA |
| - | Carmustine | powder | 57884-0032BULK INGREDIENT |
| - | Caspofungin Acetate | powder | 57884-0030BULK INGREDIENT |
| - | Cisatracurium Besylate | powder | 57884-0018BULK INGREDIENT |
| - | Cyclophosphamide | powder | 57884-0022BULK INGREDIENT |
| - | Desflurane | liquid | 57884-0028BULK INGREDIENT |
| - | Dexmedetomidine Hydrochloride | powder | 57884-0024BULK INGREDIENT |
| Docetaxel | Docetaxel | injection, solution, concentrate, intravenous | 57884-3041ANDA |
| Docetaxel | Docetaxel | injection, solution, concentrate, intravenous | 57884-3042ANDA |
| Docetaxel | Docetaxel | injection, solution, concentrate, intravenous | 57884-3043ANDA |
| - | Etoposide | powder | 57884-0008BULK INGREDIENT |
| - | Fondaparinux Sodium | powder | 57884-0026BULK INGREDIENT |
| - | Gabapentin | powder | 57884-0010BULK INGREDIENT |
| - | Gadobutrol | powder | 57884-0035BULK INGREDIENT |
| - | Gadoterate Meglumine | powder | 57884-0037BULK INGREDIENT |
| - | Ifosfamide | powder | 57884-0006BULK INGREDIENT |
| - | Iodixanol | powder | 57884-0029BULK INGREDIENT |
| - | Ioversol | powder | 57884-0015BULK INGREDIENT |
| - | Irinotecan Hydrochloride | powder | 57884-0009BULK INGREDIENT |
| - | Ivabradine Monosulfate | powder | 57884-0031BULK INGREDIENT |
| - | Letrozole | powder | 57884-0011BULK INGREDIENT |
| - | Sevoflurane | liquid | 57884-0036BULK INGREDIENT |
| - | Tolvaptan | powder | 57884-0027BULK INGREDIENT |
| - | Trabectedin | powder | 57884-0033BULK INGREDIENT |
| - | docetaxel trihydrate | powder | 57884-0014BULK INGREDIENT |
| - | oxaliplatin | powder | 57884-0017BULK INGREDIENT |
Neighbours
Registered in the same town
6- Jiangsu Hansoh Pharmaceutical Group Co., Ltd.Lianyungang, CHN · 2 sites
- Agno Pharma JiangsuLianyungang, CHN
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Lianyungang, CHN
- Lianyungang Kangle Pharmaceutical Co., Ltd.Lianyungang, CHN
- Lianyungang Runzhong Pharmaceutical Co., Ltd.,Lianyungang, CHN
- Sinopep-Allsino Biopharmaceutical Co., Ltd.Lianyungang, CHN
Compare
Comparable companies in China
- BrightGene Bio-Medical Technology Co., Ltd.4 sites · 19 NDC
- Bimeda, Inc.4 sites · 0 NDC
- Zhejiang Huahai Pharmaceutical Technology Co Ltd3 sites · 76 NDC
- Qilu Pharmaceutical Co., Ltd.5 sites · 57 NDC
- Zhejiang Xianju Pharmaceutical Co., Ltd.3 sites · 38 NDC
- Zhejiang Hisun Pharmaceutical Co., Ltd.3 sites · 27 NDC
- Viwit Pharmaceutical Co., Ltd.3 sites · 5 NDC
- Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.3 sites · 4 NDC
- Akeso Biopharma Co., Ltd3 sites · 1 NDC
- Shandong Xinhua Pharmaceutical Company Limited2 sites · 62 NDC
Enquiry
Common questions
- Is Jiangsu Hengrui Pharmaceuticals Co., Ltd. FDA approved?
- Jiangsu Hengrui Pharmaceuticals Co., Ltd. holds 4 FDA-registered establishments in China. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are Jiangsu Hengrui Pharmaceuticals Co., Ltd.'s drugs manufactured?
- The FDA register lists Lianyungang. Registered operations: analytical testing, active ingredient (API) manufacture, labelling, finished drug manufacture, packaging, particle size reduction, sterilize.
- What drugs does Jiangsu Hengrui Pharmaceuticals Co., Ltd. make?
- 28 products are listed under Jiangsu Hengrui Pharmaceuticals Co., Ltd. in the openFDA NDC Directory, most often as powder; injection, solution, concentrate; injection, suspension, liposomal. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
- Are any Jiangsu Hengrui Pharmaceuticals Co., Ltd. products in shortage?
- 3 presentations are currently listed in the FDA drug shortage database under Jiangsu Hengrui Pharmaceuticals Co., Ltd., covering Dexmedetomidine Hydrochloride Injection.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.